Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venclexta (venetoclax)
Pharma
AZ nabs Calquence fixed-duration nod to counter BeOne’s CLL push
The fixed-duration approval for Calquence arrives as BeOne continues to widen its lead in the BTK inhibitor space with Brukinsa.
Angus Liu
Feb 20, 2026 11:05am
AbbVie, Roche fail again in label expansion bid for Venclexta
Jun 16, 2025 4:23pm
AstraZeneca trumpets new Calquence combos in CLL
Jul 29, 2024 10:25am
An Imbruvica combo regimen could have a new future in MCL
Dec 12, 2023 12:33pm
AbbVie, Roche's Venclexta disappoints in multiple myeloma trial
Sep 29, 2023 11:24am
NICE signs off on AbbVie, J&J's Imbruvica-Venclyxta combo in CLL
Apr 21, 2023 11:30am
